NCT05675436View on ClinicalTrials.gov

Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease

Active, not recruitingOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

May 9, 2024

Primary Completion Date

October 27, 2027

Study Completion Date

October 27, 2027

Conditions
Sickle Cell AnemiaSickle Cell ThalassemiaSickle Cell PainHbssHbscSickle Beta ThalassemiaSickle Beta Zero ThalassemiaSickle Cell Syndrome Variant
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT05675436 - Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease | Biotech Hunter | Biotech Hunter